Popular Articles

IFPMA R&D Status Report 2009: Industry Research Increasing In Less Well-known Tropical Diseases
The IFPMA has just published the 2009 edition of its Status Report on Pharmaceutical Industry R&D for Diseases of the Developing World(1). This documents research and development projects by IFPMA member companies(2), alone or with partners, to develop medicines and vaccines for the 10 diseases of the developing world (DDW)(3) prioritized by the United Nations" TDR tropical disease research and training organization(4). Member company DDW medicine and vaccine projects have increased from 67 last year to a total of 84 this year. While the number of tuberculosis and malaria projects has grown slightly, projects for the remaining eight tropical diseases have increased markedly from 11 in 2008 to 25 in 2009.
drugs without prescription
How The Body Adapts To Exercise At Altitude And How Hypoxia Affects Muscle And Nerve Responses
Exercise requires the integrated activity of every organ and tissue in the body, and understanding how these respond to the decreased oxygen levels present at moderate to high altitude is the focus of the current special issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The entire issue is available free online at http://www.liebertpub.com/ham Guest Editor Peter D. Wagner, MD, Distinguished Professor of Medicine & Bioengineering at the University of California, San Diego, presents six review articles written by expert researchers in the field of high altitude medicine that explore various aspects of exercise at altitude, including muscle and nerve function, metabolic responses, and changes that occur at the cellular level.
News of the day
RCN Calls For EU Agreement On Sharps Injuries To Be Implemented Quickly
The Royal College of Nursing welcomed the signing of a joint agreement by European Federation of Public Service Unions (EPSU) and the European Hospital and Healthcare Employers Association (HOSPEEM). This is an EU-wide agreement which the RCN has played a key role in bringing about to prevent one million medical sharps injuries per year. Dr Peter Carter, Chief Executive of the Royal College of Nursing (RCN), said:
Cardiovascular

British Medical Association Comment On Announcement On NHS Treatment Centres

The Department of Health announced that the terms offered to independent providers of treatment centres in the NHS in England will in future be more similar to those offered to NHS providers. Commenting on the announcement, Dr Hamish Meldrum, Chairman of Council at the BMA, says: "Millions of pounds" worth of taxpayers" money has been wasted because of the government"s determination to encourage the private sector into our NHS. When the first wave of these contracts comes to an end next year, the majority of independent providers will have failed to deliver the amount of work they have been paid for. "It"s a shame it"s taken so long to get an acknowledgement that skewing the playing field in favour of private companies has been unfair and wasteful. Independent sector treatment centres have been able to cherry-pick "easier" cases, potentially destabilising existing services. Even in future, private companies will be at an advantage because when things go wrong with a patient"s care, it"s the NHS that picks up the tab. "Especially in the current climate, the NHS cannot afford poor value contracts, unnecessary competition, and duplication of services. We need much more of a whole-systems approach to the provision of healthcare, and we need the NHS to be run on the basis of co-operation collaboration, not competition." Notes 1) View a BMA briefing paper on ISTCs here. 2) The BMA is currently raising awareness of the implications of NHS market reforms through its "Look After Our NHS campaign": http://lookafterournhs.org.uk British Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):